"10.1371_journal.pone.0146705","plos one","2016-01-14T00:00:00Z","Ane Arbillaga-Etxarri; Jaume Torrent-Pallicer; Elena Gimeno-Santos; Anael Barberan-Garcia; Anna Delgado; Eva Balcells; Diego A Rodríguez; Jordi Vilaró; Pere Vall-Casas; Alfredo Irurtia; Robert Rodriguez-Roisin; Judith Garcia-Aymerich; Urban Training™ Study Group","Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; Pompeu Fabra University (UPF), Barcelona, Spain; CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Spain; FCS Blanquerna, Research Group in Physical Activity and Health (SAFE), Ramon Llull University, Barcelona, Spain; Pneumology department, Hospital Clínic of Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedicine Research Institution (IDIBAPS), University of Barcelona (UB), Barcelona, Spain; CIBER Respiratory diseases (CIBERES), Bunyola, Illes Balears, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pneumology department, Hospital del Mar, Barcelona, Spain; International University of Catalunya (UIC), Barcelona, Spain; Catalan National Institute of Physical Education (INEFC), Barcelona, Spain","Conceived and designed the experiments: JGA EGS JTP AAE. Performed the experiments: AD JTP AAE. Analyzed the data: JGA JTP AAE. Contributed reagents/materials/analysis tools: ABG RRR DAR EB PVC AI JV. Wrote the paper: AAE JTP EGS ABG AD EB DAR JV PVC AI RRR JGA.","One author (RRR) reports receipt of grants/research support from Almirall (not related to this study), lectured for Almirall, AstraZeneca, Boehringer Ingelheim, Ferrer, Menarini, Takeda, and TEVA, and consulted with Boehringer Ingelheim, Pearl, Takeda, and TEVA. AAE, JTP, EGS, ABG, AD, EB, DAG, JV, PVC, AI, and JGA have nothing to disclose. There are no patents, products in development, or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","01","Ane Arbillaga-Etxarri","AAE",13,TRUE,4,3,3,12,TRUE,TRUE,TRUE,1,"13",TRUE
